Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study

  1. Falcón González, A.
  2. Cruz Jurado, J.
  3. Llabrés Valenti, E.
  4. Urbano Cubero, R.
  5. Álamo de la Gala, M.C.
  6. Martínez Guisado, M.A.
  7. Álvarez Ambite, R.
  8. Rodríguez González, C.J.
  9. Amérigo Góngora, M.
  10. Rodríguez Pérez, L.
  11. López Álvarez, P.
  12. Sánchez Rovira, P.
  13. González Flores, E.
  14. Henao Carrasco, F.
  15. Bayo Calero, J.
  16. Valero Arbizu, M.
  17. Quílez Cutillas, A.
  18. Salvador Boffil, J.
  19. Rubio Pérez, E.
  20. Ruiz-Borrego, M.
Revue:
Clinical and Translational Oncology

ISSN: 1699-3055,  1699-048X

Année de publication: 2024

Type: Article

DOI: 10.1007/S12094-024-03440-5 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus